Paradigm Biocapital Advisors »

Keros Therapeutics shares owned by Paradigm Biocapital Advisors

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Paradigm Biocapital Advisors from 13F filings

Historical chart of Paradigm Biocapital Advisors investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Paradigm Biocapital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $31M 525k 58.07
2023-03-31 $40M 931k 42.70